সংরক্ষণ করুন:
| প্রধান লেখক: | , , , |
|---|---|
| বিন্যাস: | Recurso digital |
| ভাষা: | |
| প্রকাশিত: |
Zenodo
2025
|
| অনলাইন ব্যবহার করুন: | https://doi.org/10.5281/zenodo.14716934 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
সূচিপত্রের সারণি:
- <p>Hypercholesterolemia, is a condition that increase cholesterol levels in body and it is major risk factor for cardiovascular disease (CVD). In the treatment of this condition statins, bile acid sequestrants, and cholesterol absorption inhibitors are use but they show side effects especially statin are cause muscle-related complications. Bempedoic acid is new drug that lower the lipid and it is alternative of other medicine. It is use in statin-intolerant patients or those with familial hypercholesterolemia. Bempedoic acid inhibit ATP- citrate lyase which is produce factor of cholesterol and reduce level of LDL-C without any muscle-related adverse effects which are show in statins. This review article explores Bempedoic acid’s mechanism of action, its clinical efficacy in management of hypercholesterolemia, and its potential as a complementary or alternative therapy to traditional lipid-lowering treatments. Given its unique mechanism, Bempedoic acid offers a valuable advancement in the pharmacological management of hypercholesterolemia and cardiovascular risk.</p>